Medicine discount for private health insurers

Categories: ECJ case law · Sales tax
Tags: Drug discount · Assessment basis
A statutory deduction can reduce the proceeds remaining with the manufacturer, even though the manufacturer and insurer have not concluded a direct purchase agreement. The delivery and reimbursement chain must be traceable as a whole.
What matters in each individual case
To prove this, it is not enough to add up all of the company's bonuses and deductions. Private reimbursement systems and other sales channels should remain distinguishable in the evaluation.
Practical case and recommendation for action
A manufacturer deducts the discount as a flat rate from the monthly sales. Assign discount invoices to the affected drugs and delivery periods and exclude double consideration.
A useful reconciliation first shows the agreed gross price and then every payment, discount and refund. Record who is responsible for the respective amount and whether it can be assigned to a specific turnover. This can prevent a cash flow between two other parties from being treated as separate sales or a credit being taken into account in two accounting periods.
Three more test situations
In the case of a collective credit, name all affected original invoices.
For third-party payments, determine the specific contractual reason and the final recipient.
When returning goods, coordinate the original delivery, the return shipping and the refund amount.
Legal source and advice
ECJ, judgment of December 20, 2017 · C-462/16
Further advice from the law firm: Sales tax on deliveries and services.